These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18680438)

  • 41. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
    Lappin G; Garner RC
    Nat Rev Drug Discov; 2003 Mar; 2(3):233-40. PubMed ID: 12612650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantifying exploratory low dose compounds in humans with AMS.
    Dueker SR; Vuong le T; Lohstroh PN; Giacomo JA; Vogel JS
    Adv Drug Deliv Rev; 2011 Jun; 63(7):518-31. PubMed ID: 21047543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique.
    Young G; Ellis W; Ayrton J; Hussey E; Adamkiewicz B
    Xenobiotica; 2001; 31(8-9):619-32. PubMed ID: 11569529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Accelerating clinical insights: how to use accelerator mass spectrometry to make better early development decisions.
    Seymour M
    Altern Lab Anim; 2010 Dec; 38 Suppl 1():15-20. PubMed ID: 21275478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute oral bioavailability and metabolic turnover of β-sitosterol in healthy subjects.
    Duchateau G; Cochrane B; Windebank S; Herudzinska J; Sanghera D; Burian A; Müller M; Zeitlinger M; Lappin G
    Drug Metab Dispos; 2012 Oct; 40(10):2026-30. PubMed ID: 22826463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of accelerator mass spectrometry to measure the pharmacokinetics and peripheral blood mononuclear cell concentrations of zidovudine.
    Vuong le T; Ruckle JL; Blood AB; Reid MJ; Wasnich RD; Synal HA; Dueker SR
    J Pharm Sci; 2008 Jul; 97(7):2833-43. PubMed ID: 17854048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics, bioavailability, metabolism, and tissue distribution of cidofovir (HPMPC) and cyclic HPMPC in rats.
    Cundy KC; Bidgood AM; Lynch G; Shaw JP; Griffin L; Lee WA
    Drug Metab Dispos; 1996 Jul; 24(7):745-52. PubMed ID: 8818571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overcoming bioanalytical challenges in an Onglyza(®) intravenous [(14)C]microdose absolute bioavailability study with accelerator MS.
    Xu XS; Dueker SR; Christopher LJ; Lohstroh PN; Keung CF; Cao KK; Bonacorsi SJ; Cojocaru L; Shen JX; Humphreys WG; Stouffer B; Arnold ME
    Bioanalysis; 2012 Aug; 4(15):1855-70. PubMed ID: 22943617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs.
    Barrish A; Olah TV; Gatto GJ; Michel KB; Dobrinska MR; Gilbert JD
    Rapid Commun Mass Spectrom; 1996; 10(9):1033-7. PubMed ID: 8755236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
    Turteltaub KW; Vogel JS; Frantz CE; Fultz E
    IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precision and accuracy in the quantitative analysis of biological samples by accelerator mass spectrometry: application in microdose absolute bioavailability studies.
    Gao L; Li J; Kasserra C; Song Q; Arjomand A; Hesk D; Chowdhury SK
    Anal Chem; 2011 Jul; 83(14):5607-16. PubMed ID: 21627104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.
    Enright HA; Malfatti MA; Zimmermann M; Ognibene T; Henderson P; Turteltaub KW
    Chem Res Toxicol; 2016 Dec; 29(12):1976-1986. PubMed ID: 27726383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceptable and unacceptable procedures in bioavailability and bioequivalence trials.
    Marzo A; Ceppi Monti N
    Pharmacol Res; 1998 Nov; 38(5):401-4. PubMed ID: 9806821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accelerator mass spectrometry.
    Hellborg R; Skog G
    Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical pharmacokinetic registration file for NDA and ANDA procedures.
    Marzo A
    Pharmacol Res; 1997 Dec; 36(6):425-50. PubMed ID: 9446710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New ultrasensitive detection technologies and techniques for use in microdosing studies.
    Lappin G; Wagner CC; Langer O; van de Merbel N
    Bioanalysis; 2009 May; 1(2):357-66. PubMed ID: 21083172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14C-microdose, Humanized Mice, Monkey Pharmacokinetics, and In Vitro Methods.
    Jensen KG; Jacobsen AM; Bundgaard C; Nilausen DØ; Thale Z; Chandrasena G; Jørgensen M
    Drug Metab Dispos; 2017 Jan; 45(1):68-75. PubMed ID: 27737930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
    Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.